[{"address1": "120 Presidential Way", "address2": "Suite 330", "city": "Woburn", "state": "MA", "zip": "01801", "country": "United States", "phone": "781-245-1325", "website": "https://www.biofrontera-us.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.", "fullTimeEmployees": 81, "companyOfficers": [{"maxAge": 1, "name": "Dr. Hermann  Luebbert Ph.D.", "age": 67, "title": "CEO, President & Executive Chairman", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 733225, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eugene Frederick Leffler III", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 378578, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erica F. Gates CPA, M.B.A.", "title": "Senior Director of Finance & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon  Lyons M.B.A., Ph.D.", "title": "Vice President of Scientific & Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alycia  Torres", "title": "Vice President of Administration", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Hakansson J.D.", "title": "General Counsel & Head of Compliance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Samantha  Widdicombe", "title": "Senior Director of Strategic Accounts & Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Baldyga", "title": "Vice President of & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.24, "dayLow": 0.7911, "dayHigh": 1.24, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.24, "regularMarketDayLow": 0.7911, "regularMarketDayHigh": 1.24, "beta": 0.782, "forwardPE": -0.29967427, "volume": 9170329, "regularMarketVolume": 9170329, "averageVolume": 48605, "averageVolume10days": 31140, "averageDailyVolume10Day": 31140, "bid": 0.89, "ask": 0.9139, "bidSize": 1000, "askSize": 1800, "marketCap": 1549859, "fiftyTwoWeekLow": 0.7911, "fiftyTwoWeekHigh": 18.36, "priceToSalesTrailing12Months": 0.046100687, "fiftyDayAverage": 2.73162, "twoHundredDayAverage": 7.345835, "currency": "USD", "enterpriseValue": -2552782, "profitMargins": -0.78652, "floatShares": 870952, "sharesOutstanding": 1684630, "sharesShort": 31179, "sharesShortPriorMonth": 35034, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.020499999, "heldPercentInsiders": 0.37855, "heldPercentInstitutions": 0.14838, "shortRatio": 0.32, "shortPercentOfFloat": 0.027999999, "impliedSharesOutstanding": 1684630, "bookValue": 0.759, "priceToBook": 1.2121212, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -26442000, "trailingEps": -20.36, "forwardEps": -3.07, "lastSplitFactor": "1:20", "lastSplitDate": 1688515200, "enterpriseToRevenue": -0.076, "enterpriseToEbitda": 0.119, "52WeekChange": -0.92583334, "SandP52WeekChange": 0.19340658, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BFRI", "underlyingSymbol": "BFRI", "shortName": "Biofrontera Inc.", "longName": "Biofrontera Inc.", "firstTradeDateEpochUtc": 1635514200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f81dad8d-7768-38b3-a53c-f0f095b62379", "messageBoardId": "finmb_531568773", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.92, "targetHighPrice": 33.0, "targetLowPrice": 7.0, "targetMeanPrice": 20.0, "targetMedianPrice": 20.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 6763000, "totalCashPerShare": 4.456, "ebitda": -21433000, "totalDebt": 2814000, "quickRatio": 0.362, "currentRatio": 1.017, "totalRevenue": 33619000, "debtToEquity": 271.098, "revenuePerShare": 25.217, "returnOnAssets": -0.30754, "returnOnEquity": -2.23772, "freeCashflow": -3409500, "operatingCashflow": -24300000, "revenueGrowth": 1.058, "grossMargins": 0.48446, "ebitdaMargins": -0.63752997, "operatingMargins": -0.49685, "financialCurrency": "USD", "trailingPegRatio": null}]